Prevention of Paclitaxel Neuropathy With Cryotherapy
The purpose of this study is to determine if cryotherapy can effectively decrease the rate of neuropathy in patients undergoing weekly paclitaxel treatments.
Breast Cancer
OTHER: Cryotherapy|DRUG: Paclitaxel
Incidence of grade 2 peripheral neuropathies induced by weekly paclitaxel., From the date of randomization until date of first documented incidence of grade 2 peripheral neuropathy, assessed up to 2 years.
Rate of completion of weekly adjuvant paclitaxel with the use of cryotherapy., From the date of randomization until date of first documented incidence of grade 2 peripheral neuropathy, assessed up to 2 years.
The purpose of this study is to determine if cryotherapy can effectively decrease the rate of neuropathy in patients undergoing weekly paclitaxel treatments.